Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Price Restraint Hits McKesson; Wholesaler Sees Delay, Not Policy Change

Executive Summary

Pharmaceutical price increases remain a critical component of manufacturers' commercial strategies, McKesson CEO John Hammergren assured analysts during the Thomas Weisel Partners Healthcare Conference in Boston Sept. 9

You may also be interested in...



Pfizer Says No To “Fee-For-Service” Contracts; Cardinal, Eisai Reach Deal

Pfizer is not involved in "fee-for-service" negotiations with wholesalers, the company declared in its fourth quarter earnings release Jan. 19

Pfizer Says No To “Fee-For-Service” Contracts; Cardinal, Eisai Reach Deal

Pfizer is not involved in "fee-for-service" negotiations with wholesalers, the company declared in its fourth quarter earnings release Jan. 19

Rx Prices Will Rise 5% Prior To Start Of Medicare Drug Benefit, ABC Says

AmerisourceBergen is confident that drug prices will rise 5% ahead of the Jan. 1, 2006 start of the Medicare drug benefit, CFO Michael DiCandilo said

Related Content

Topics

UsernamePublicRestriction

Register

LL009864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel